advertisement

---

Sgambellone S 16

Showing records 1 to 16 | Display all abstracts from Sgambellone S

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Sgambellone S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Kilbile JT; Sapkal SB
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Khanfar MA
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Renzi G
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Marri S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
D'Agostino I
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Villano S
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Boudjelal M
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Nardini P; Frank A
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Tamboli Y
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Reiner-Link D
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Cutarella L; Mori M
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Stark H
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Sgambellone S
ChemMedChem 2024; 19: e202400601

---

122419 Histamine H receptor antagonist/nitric oxide donors as novel promising therapeutic hybrid-tools for glaucoma and retinal neuroprotection
Lucarini L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 180: 117454

---

120751 Lasamide Containing Sulfonylpiperazines as Effective Agents for the Management of Glaucoma Associated Symptoms
Villano S; Marri S; Lucarini L; Carradori S; Carta F; Supuran CT
ChemMedChem 2024; 19: e202400601

---